These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21763725)

  • 1. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors.
    Knox JE; Ma NL; Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
    J Med Chem; 2006 Nov; 49(22):6585-90. PubMed ID: 17064076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
    Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
    Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
    Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
    Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.
    Ganesh VK; Muller N; Judge K; Luan CH; Padmanabhan R; Murthy KH
    Bioorg Med Chem; 2005 Jan; 13(1):257-64. PubMed ID: 15582469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y; Samanta S; Cui T; Lam Y
    ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.
    Bastos Lima A; Behnam MA; El Sherif Y; Nitsche C; Vechi SM; Klein CD
    Bioorg Med Chem; 2015 Sep; 23(17):5748-55. PubMed ID: 26233795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H; Singh NJ; Kim KS
    Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses.
    Braun NJ; Quek JP; Huber S; Kouretova J; Rogge D; Lang-Henkel H; Cheong EZK; Chew BLA; Heine A; Luo D; Steinmetzer T
    ChemMedChem; 2020 Aug; 15(15):1439-1452. PubMed ID: 32501637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
    de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
    J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.
    Lai H; Dou D; Aravapalli S; Teramoto T; Lushington GH; Mwania TM; Alliston KR; Eichhorn DM; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2013 Jan; 21(1):102-13. PubMed ID: 23211969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.
    Nitsche C; Behnam MA; Steuer C; Klein CD
    Antiviral Res; 2012 Apr; 94(1):72-9. PubMed ID: 22391061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.